ப்ரிமியர் கல்வி நிகழ்வு கவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரிமியர் கல்வி நிகழ்வு கவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரிமியர் கல்வி நிகழ்வு கவனம் Today - Breaking & Trending Today

Pfizer and Moderna haven't proven their COVID-19 vaccines shield against new variants: analysts


Jan 28, 2021 10:52am
One infectious disease specialist said efforts to determine if existing vaccines will work against new COVID strains have left us in a state of ignorance due to incomplete data.(Bill Oxford/Getty Images)
Just as the U.S. government is starting to ramp up purchases of Pfizer’s and Moderna’s mRNA vaccines to prevent COVID-19, a troubling question is emerging in the scientific community: Can these shots protect people against aggressive new variants racing through the U.K., South Africa and Brazil?
Several analysts have scoured the medical literature and interviewed infectious disease experts in an effort to answer that question. Their conclusion? There is no clear answer. At least not yet. ....

South Africa , South African , Leerink Porges , Geoffrey Porges , Joe Biden , Clinical Trials Summit , Premier Educational Event Focused , Decentralized Clinical , Umer Raffat , President Joe Biden , Moderna Therapeutics , Svb Leerink , Covid 19 , Preventive Vaccines , ஜெஃப்ரி போற்கேஸ் , ஓஹோ பிடென் , மருத்துவ சோதனைகள் உச்சிமாநாடு , ப்ரிமியர் கல்வி நிகழ்வு கவனம் , ப்ரெஸிடெஂட் ஓஹோ பிடென் , மாடர்னா சிகிச்சை , ப்ரெவெஂடிவ் தடுப்பு மருந்துகள் ,

Scramble for specialty syringes as Pfizer, feds look to extract 6th vaccine doses


Jan 28, 2021 10:36am
Pfizer and BioNTech s COVID-19 vaccine vials contain an extra doses of the in-demand shot, but those doses can only be accessed with a special needle.(Kunal Mahto/iStock/Getty Images Plus/Getty Images)
Syringe makers are scrambling to meet demand for so-called low dead space syringes as Pfizer and the U.S. look to squeeze out extra vaccine doses. The specialty needles are needed to eke out a sixth shot in Pfizer and BioNTech s Comirnaty prepared five-dose glass vials.
Physicians and pharmacists discovered the potential extra dose after they began vaccinating patients. But initial enthusiasm has been dampened by the requirement of the now-scarce specialty needles to extract the last bit from each vial. ....

District Of Columbia , United States , United Kingdom , Biontech Comirnaty , Sam Buffone , Joe Biden , Washington Post , Becton Dickinson , Fierce Pharma , Clinical Trials Summit , Premier Educational Event Focused , Decentralized Clinical , Defense Protection Act , Joseph Biden , Covid 19 , Vaccine Delivery , மாவட்டம் ஆஃப் கொலம்பியா , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஓஹோ பிடென் , வாஷிங்டன் போஸ்ட் , பெக்டன் டிக்கின்சன் , கடுமையான பார்மா , மருத்துவ சோதனைகள் உச்சிமாநாடு , ப்ரிமியர் கல்வி நிகழ்வு கவனம் , பாதுகாப்பு ப்ரொடெக்ஶந் நாடகம் ,

Ultragenyx earns 2 rare disease drug approvals—and a validated commercial strategy


Jan 29, 2021 9:45am
Ultragenyx nabbed its third and fourth FDA approvals in 2020 and pushed through the pandemic by reaching out to patients directly. (Ultragenyx)
Rare disease pharma companies spend a lot of time looking for patients and investing in keeping them on their meds.
But what happens during a pandemic lockdown? At Ultragenyx, patient support teams kicked into high gear, making thousands of proactive outbound calls to find out what patients needed to continue their treatment.
It had just nabbed a second approval for FGF23 hormone blocker Crysvita in June 2020 for tumor-induced osteomalacia. The first nod for the drug, developed by Ultragenyx and partner Kyowa Kirin, came in April 2018 for X-linked hypophosphatemia. ....

Ultragenyx Crysvita , Erik Harris , Piper Sandler , Kyowa Kirin , Clinical Trials Summit , Premier Educational Event Focused , Decentralized Clinical , Commercial Officer Erik Harris , ஏறிக் ஹாரிஸ் , பைபர் சாண்ட்லர் , கியோவா கிரீன் , மருத்துவ சோதனைகள் உச்சிமாநாடு , ப்ரிமியர் கல்வி நிகழ்வு கவனம் , வணிகரீதியானது அதிகாரி ஏறிக் ஹாரிஸ் ,

Lilly amps Type 1 diabetes partnerships to reach more young people


Jan 28, 2021 10:30am
Eli Lilly is expanding its global Type 1 diabetes efforts to provide insulin supplies and education to young people. (Eli Lilly)
Eli Lilly is renewing and expanding a longtime Type 1 diabetes partnership to support more than six times as many children in the next 10 years.
Working with Life for a Child, Lilly plans to expand care to 150,000 young people with diabetes over the next decade, up from 23,000 last year. The global initiative provides free immediate care with medicine and equipment like reusable pens and monitors, but also longer-term education and support in living with the chronic illness.
As part of the new push, Life for a Child is joining with diabetes non-profit and advocacy group Beyond Type 1. That well-known group s four co-founders include Jonas Brothers singer Nick Jonas and Top Chef alum Sam Talbot from the Bravo TV series. The group claims to be the largest diabetes online organization with a myriad of efforts that f ....

Mike Mason , Sam Talbot , Eli Lilly , Nick Jonas , Beyond Type , Top Chef Sam Talbot , Clinical Trials Summit , Premier Educational Event Focused , Decentralized Clinical , Top Chef , Lilly Diabetes , மைக் கொத்தனார் , சாம் டால்போட் , எலி லில்லி , நிக் ஜோனாஸ் , அப்பால் வகை , மேல் செஃப் சாம் டால்போட் , மருத்துவ சோதனைகள் உச்சிமாநாடு , ப்ரிமியர் கல்வி நிகழ்வு கவனம் , மேல் செஃப் , லில்லி நீரிழிவு நோய் ,